Autonomix Medical (AMIX) Stock Price, News & Analysis

Company Overview

Autonomix Medical, Inc. is a medical device company developing catheter-based technologies intended to diagnose and treat conditions involving the peripheral nervous system. The company’s platform uses a miniature sensing chip integrated into a catheter to detect and measure nerve signals in targeted areas of the body.

Autonomix is initially focused on applications in pain management, including the detection and treatment of nerves associated with chronic and cancer-related pain. Its technology is designed to help physicians identify relevant nerves more precisely and guide procedures such as targeted nerve ablation or other therapeutic interventions.

The company’s development programs remain subject to clinical testing, regulatory review and authorization before any products can be broadly commercialized. Autonomix Medical is headquartered in the United States and focuses primarily on developing its platform for use by physicians and healthcare providers.

Key Stats

• Today's Range: $3.54 to $3.73
• 50-Day Range: $2.75 to $19.50
• 52-Week Range: $2.44 to $32.55
• Volume: 133,292 shs
• Average Volume: 224,946 shs
• Market Capitalization: $3.43 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $42.00
• Consensus Rating: Hold

Autonomix Medical Stock Analysis - MarketRank™

Autonomix Medical scored higher than 36% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

Autonomix Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.

Upside Potential

Autonomix Medical has a consensus price target of $42.00, representing about 1,086.4% upside from its current price of $3.54.

Amount of Analyst Coverage

Autonomix Medical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Autonomix Medical are expected to grow in the coming year, from ($20.17) to ($17.44) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Autonomix Medical is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Autonomix Medical is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Autonomix Medical has a P/B Ratio of 0.33. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.69% of the float of Autonomix Medical has been sold short.

Short Interest Ratio / Days to Cover

Autonomix Medical has a short interest ratio ("days to cover") of 0.64, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Autonomix Medical has recently increased by 4.78%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Autonomix Medical does not currently pay a dividend.

Dividend Growth

Autonomix Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 5 news articles for Autonomix Medical this week, compared to 3 articles on an average week.

Search Interest

Only 4 people have searched for AMIX on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.

MarketBeat Follows

2 people have added Autonomix Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Autonomix Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

5.50% of the stock of Autonomix Medical is held by insiders.

Percentage Held by Institutions

10.78% of the stock of Autonomix Medical is held by institutions.

Company Calendar

• Last Earnings: 8/12/2026
• Today: 10/05/2026
• Next Earnings (Estimated): 11/11/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:AMIX
• Previous Symbol: NASDAQ:AMIX
• CIK: 1617867
• Web: autonomix.com
• Phone: 713-588-6150
• Fax: N/A
• Employees: 11
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Autonomix Medical: $42.00
• High Price Target: $42.00
• Low Price Target: $42.00
• Potential Upside/Downside: +1,086.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($41.57)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$16.72 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -267.73%
• Return on Assets: -216.75%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.85
• Quick Ratio: 4.85

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $10.85 per share
• Price / Book: 0.33

Miscellaneous

• Outstanding Shares: 970,000
• Free Float: 918,000
• Market Cap: $3.43 million
• Optionable: N/A
• Beta: -0.96